Domer J E, Human L G, Andersen G B, Rudbach J A, Asherson G L
Department of Microbiology and Immunology, Tulane University School of Medicine, New Orleans, Louisiana 70112-2699.
Infect Immun. 1993 May;61(5):2122-30. doi: 10.1128/iai.61.5.2122-2130.1993.
Monophosphoryl lipid A (MLA), derived either from Salmonella minnesota or Salmonella typhimurium, was tested for its ability to alter Candida albicans mannan (MAN)-specific suppression. Since we showed previously that naive mice injected intravenously (i.v.) with MAN developed suppressor T cells capable of down-regulating delayed-type hypersensitivity when transferred to immunized recipients, MLA was tested for its ability to influence suppressor activity in the donors of suppressor cells. T-lymphocyte-enriched suspensions from donor mice treated with MLA, especially that derived from S. typhimurium, 2 or 3 days after the injection of MAN lost the ability to suppress delayed-type hypersensitivity when transferred to immunized mice. Transferable suppressor activity was reduced but not always completely abrogated when donor animals were treated with MLA 1 day following the administration of MAN. In several experiments, S. minnesota MLA also abrogated activity, but it was not effective in other transfer experiments. In a different type of experiment, MLA was given to immunized mice which had been suppressed directly with MAN. Mice were immunized, either by the introduction of C. albicans intragastrically followed by inoculation intradermally (i.d.) or by two i.d. inoculations, and MAN-specific suppressor cells were induced in such animals by the i.v. injection of MAN 1 day before the first or second i.d. inoculation in animals given intragastric plus i.d. inoculations and those given two i.d. inoculations, respectively. MLA was administered to such mice prior to the i.v. injection of MAN, on the same day, or 1 to 4 days thereafter. S. typhimurium MLA, especially when given to mice 2 days following the administration of MAN, caused a partial abrogation of suppressor activity. Overall, however, MLA, at 5 to 100 micrograms, had variable and minimal effects on suppressor activity in immunized mice suppressed by the i.v. administration of MAN. In summary, MLA is clearly capable of abrogating MAN-induced suppression when given to nonimmunized animals in which MAN-specific suppressor cells had been induced, but its efficacy in immunized animals suppressed by the i.v. administration of MAN was marginal.
对来源于明尼苏达沙门氏菌或鼠伤寒沙门氏菌的单磷酰脂质A(MLA)改变白色念珠菌甘露聚糖(MAN)特异性抑制作用的能力进行了检测。因为我们之前发现,静脉注射(i.v.)MAN的未免疫小鼠会产生抑制性T细胞,当将这些细胞转移至免疫的受体时,它们能够下调迟发型超敏反应,所以检测了MLA影响抑制性细胞供体中抑制活性的能力。在注射MAN后2或3天,用MLA处理的供体小鼠中富含T淋巴细胞的悬浮液,尤其是来源于鼠伤寒沙门氏菌的悬浮液,转移至免疫小鼠后失去了抑制迟发型超敏反应的能力。当在给予MAN后1天用MLA处理供体动物时,可转移的抑制活性降低,但并不总是完全消除。在几个实验中,明尼苏达沙门氏菌MLA也消除了活性,但在其他转移实验中无效。在另一类实验中,将MLA给予直接被MAN抑制的免疫小鼠。小鼠通过以下方式免疫:要么先经胃内接种白色念珠菌,随后皮内(i.d.)接种,要么进行两次皮内接种;在分别给予胃内加皮内接种和两次皮内接种的动物中,在第一次或第二次皮内接种前1天通过静脉注射MAN在这些动物中诱导产生MAN特异性抑制细胞。在静脉注射MAN之前、同一天或之后1至4天,将MLA给予此类小鼠。鼠伤寒沙门氏菌MLA,尤其是在给予MAN后2天给予小鼠时,会导致抑制活性部分消除。然而,总体而言,5至100微克的MLA对经静脉注射MAN抑制的免疫小鼠中的抑制活性具有可变且微小的影响。总之,当给予已诱导产生MAN特异性抑制细胞的未免疫动物时,MLA显然能够消除MAN诱导的抑制作用,但其在经静脉注射MAN抑制的免疫动物中的效果有限。